Published in Cancer Weekly, November 7th, 2000
The research was reported in the Journal of Clinical Oncology.
In the past, physicians have relied on traditional doses of chemotherapy to treat infants afflicted with leukemia, prescribing HDC to very few of them because of fear of toxicity. But the new study, the largest of its kind, concluded that HDC is safe and beneficial if offered within four months of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.